Evidence map›Paper›PMID 31498869›Full record

Observational studyThe Journal of clinical endocrinology and metabolism2019

Cord Blood Metabolomics: Association With Newborn Anthropometrics and C-Peptide Across Ancestries.

Rachel Kadakia, Octavious Talbot, Alan Kuang, James R Bain, Michael J Muehlbauer, Robert D Stevens, Olga R Ilkayeva, Lynn P Lowe, Boyd E Metzger, Christopher B Newgard and 3 more

Registry-linked trialOpen access · bronzeAbstract readObservational Study
In one paragraph

Observational study in The Journal of clinical endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05124457 (A Phase 2 Open Label Randomized Controlled Trial Determir Vs Neutral Protamine Hagedorn), which is not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05124457 phase2recruitingnot on this mapstarted 2022, after this paper: background citation

A Phase 2 Open Label Randomized Controlled Trial Determir Vs Neutral Protamine Hagedorn (NPH) In Pregnant Women: DETERMINE Study

TypeinterventionalSponsorUniversity of California, Los AngelesRan2022 to 2025Enrolled336ConditionsGestational Diabetes, Diabetes Mellitus, Type 2ArmsInsulin Detemir, Insulin NPH
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Can the triglyceride-glucose index predict insulin resistance in LGA newborns?Journal of perinatology : official journal of the California Perinatal Association · 2023
    Article
  13. Article
  14. Article
  15. Cord Blood Plasma Metabolome-wide Associations With Height From Birth to Adolescence.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Rachel KadakiaFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
Octavious TalbotFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
Alan KuangFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
James R BainSarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina.
Michael J MuehlbauerSarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina.
Robert D StevensSarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina.
Olga R IlkayevaSarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina.
Lynn P LoweFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
Boyd E MetzgerFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
Christopher B NewgardSarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina.
Denise M ScholtensFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
William L LoweFeinberg School of Medicine, Northwestern University, Chicago, Illinois.
HAPO Study Cooperative Research Group
Northwestern University · USDuke University · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)R01HD034243 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI METZGER, BOYD E · 1999 to 2010
$16.2M
HAPO: DATA COORDINATING CENTERR01HD034242 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DYER, ALAN R · 1999 to 2007
$3.0M
Predicting Newborn and Childhood Adiposity: An Integrated Omics ApproachR01DK117491 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LOWE, WILLIAM L, SCHOLTENS, DENISE M · 2018 to 2022
$2.8M
Maternal Obesity and Gestational Diabetes: Impact on MetabolomeR01DK095963 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LOWE, WILLIAM L · 2013 to 2016
$1.7M
NCATS NIH HHS UL1 TR001422NCATS NIH HHS UL1 TR002548NICHD NIH HHS R01 HD034242NICHD NIH HHS R01 HD034243NIDDK NIH HHS R01 DK095963NIDDK NIH HHS R01 DK117491
6 · The paper itself

Abstract

contextNewborn adiposity is associated with childhood obesity. Cord blood metabolomics is one approach that can be used to understand early-life contributors to adiposity and insulin resistance.

objectiveTo determine the association of cord blood metabolites with newborn adiposity and hyperinsulinemia in a multiethnic cohort of newborns.

designCross-sectional, observational study.

settingHyperglycemia and Adverse Pregnancy Outcome study.

participantsOne thousand six hundred multiethnic mother-newborn pairs.

main outcome measureCord blood C-peptide, birthweight, and newborn sum of skinfolds.

resultsMeta-analyses across four ancestry groups (Afro-Caribbean, Northern European, Thai, and Mexican American) demonstrated significant associations of cord blood metabolites with cord blood C-peptide, birthweight, and newborn sum of skinfolds. Several metabolites, including branched-chain amino acids (BCAAs), medium- and long-chain acylcarnitines, nonesterified fatty acids, and triglycerides were negatively associated with cord C-peptide but positively associated with birthweight and/or sum of skinfolds. 1,5-Anhydroglucitol, an inverse marker of recent maternal glycemia, was significantly inversely associated with birthweight and sum of skinfolds. Network analyses revealed groups of interrelated amino acid, acylcarnitine, and fatty acid metabolites associated with all three newborn outcomes.

conclusionsCord blood metabolites are associated with newborn size and cord blood C-peptide levels after adjustment for maternal body mass index and glucose during pregnancy. Negative associations of metabolites with C-peptide at birth were observed. 1,5-Anhydroglucitol appears to be a marker of adiposity in newborns. BCAAs were individually associated with birthweight and demonstrated possible associations with newborn adiposity in network analyses.

Indexed as

AdiposityAdultAnthropometryBiomarkersBirth WeightC-PeptideCross-Sectional StudiesEthnicityFemaleFetal BloodGlucose Tolerance TestHumansHyperglycemiaHyperinsulinismInfant, NewbornMaleBiomarkersC-Peptide

Identifiers

PMID31498869
PMCPMC6735762
OpenAlexW2944116273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.